Literature DB >> 31165969

Production of semi-biosynthetic nepetalactone in yeast.

John M Billingsley1, Jose L Anguiano1, Yi Tang2,3.   

Abstract

Microbial-based production of natural products provides a promising alternative to synthetic production and isolation from the native producer. The recently discovered NEPS1 cyclase/oxidase completes the biosynthetic pathway to nepetalactone, a biologically relevant iridoid known as both an insect repellent and cat attractant. In this work, we employ yeast-based whole-cell biocatalysis to produce semi-biosynthetic nepetalactone from a low-cost precursor via a four-step enzymatic process. The dependence of product yield on bioprocess parameters ranging from induction of gene expression to substrate loading was investigated. Subsequent factorial design and response surface methodology optimization approach enabled a 5.8-fold increase in nepetalactone titer to 153 mg/L. Our study provides insights into strategies for operating plasmid-based bioconversion of a fed substrate and sets the stage for scalable, microbial synthesis of nepetalactone.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31165969      PMCID: PMC6927397          DOI: 10.1007/s10295-019-02199-x

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  14 in total

1.  Complete biosynthesis of opioids in yeast.

Authors:  Stephanie Galanie; Kate Thodey; Isis J Trenchard; Maria Filsinger Interrante; Christina D Smolke
Journal:  Science       Date:  2015-08-13       Impact factor: 47.728

2.  Bioprocess optimization using design-of-experiments methodology.

Authors:  Carl-Fredrik Mandenius; Anders Brundin
Journal:  Biotechnol Prog       Date:  2008 Nov-Dec

Review 3.  Biological and pharmacological activities of iridoids: recent developments.

Authors:  Rosa Tundis; Monica R Loizzo; Federica Menichini; Giancarlo A Statti; Francesco Menichini
Journal:  Mini Rev Med Chem       Date:  2008-04       Impact factor: 3.862

4.  Evaluation of the Saccharomyces cerevisiae ADH2 promoter for protein synthesis.

Authors:  K Michael Lee; Nancy A DaSilva
Journal:  Yeast       Date:  2005-04-30       Impact factor: 3.239

5.  Use of expression-enhancing terminators in Saccharomyces cerevisiae to increase mRNA half-life and improve gene expression control for metabolic engineering applications.

Authors:  Kathleen A Curran; Ashty S Karim; Akash Gupta; Hal S Alper
Journal:  Metab Eng       Date:  2013-07-12       Impact factor: 9.783

Review 6.  Technology development for natural product biosynthesis in Saccharomyces cerevisiae.

Authors:  John M Billingsley; Anthony B DeNicola; Yi Tang
Journal:  Curr Opin Biotechnol       Date:  2016-03-16       Impact factor: 9.740

7.  Synthesis of 8-Hydroxygeraniol.

Authors:  Francesca M Ippoliti; Joyann S Barber; Yi Tang; Neil K Garg
Journal:  J Org Chem       Date:  2018-07-23       Impact factor: 4.354

8.  Complete biosynthesis of cannabinoids and their unnatural analogues in yeast.

Authors:  Xiaozhou Luo; Michael A Reiter; Leo d'Espaux; Jeff Wong; Charles M Denby; Anna Lechner; Yunfeng Zhang; Adrian T Grzybowski; Simon Harth; Weiyin Lin; Hyunsu Lee; Changhua Yu; John Shin; Kai Deng; Veronica T Benites; George Wang; Edward E K Baidoo; Yan Chen; Ishaan Dev; Christopher J Petzold; Jay D Keasling
Journal:  Nature       Date:  2019-02-27       Impact factor: 49.962

9.  Uncoupled activation and cyclization in catmint reductive terpenoid biosynthesis.

Authors:  Benjamin R Lichman; Mohamed O Kamileen; Gabriel R Titchiner; Gerhard Saalbach; Clare E M Stevenson; David M Lawson; Sarah E O'Connor
Journal:  Nat Chem Biol       Date:  2018-12-10       Impact factor: 16.174

Review 10.  Rules for biocatalyst and reaction engineering to implement effective, NAD(P)H-dependent, whole cell bioreductions.

Authors:  Regina Kratzer; John M Woodley; Bernd Nidetzky
Journal:  Biotechnol Adv       Date:  2015-09-03       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.